< Home < Back

Biocon informs about press release

Date: 09-07-2026
Biocon has informed that it enclosed the press release titled ‘Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.